Rifadin

Active Ingredient(s): Rifampin
FDA Approved: * May 21, 1971
Pharm Company: * SANOFI AVENTIS US
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Rifadin Overview

Rifampicin, also known as rifampin, is an antibiotic used to treat several types of bacterial infections, including tuberculosis (TB), Mycobacterium avium complex, leprosy, and Legionnaires’ disease.[2] It is almost always used together with other antibiotics with two notable exceptions: when given as a "preferred treatment that is strongly recommended"[3] for latent TB infection; and when used as post-exposure prophylaxis to prevent Haemophilus influenza...

Read more Rifadin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rifampicin

Recent Rifadin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Rifampin
  • Capsule: 150mg, 300mg
  • Injection: 600mg, 600mg/vial
  • Powder: 600mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rifadin: (2 results)

Sorted by National Drug Code
  • 0068-0508 Rifadin 300 mg Oral Capsule by Sanofi-aventis U.S. LLC
  • 0068-0510 Rifadin 150 mg Oral Capsule by Sanofi-aventis U.S. LLC

Other drugs which contain Rifampin or a similar ingredient: (7 results)